Previous Article | Next Article ![]()
Mol. Cell. Biol., Jul 1996, 3465-3471, Vol 16, No. 7
DE Afar, H Park, BW Howell, DJ Rawlings, J Cooper and ON Witte
Loss of function of Bruton's tyrosine kinase (Btk) results in X-linked
immunodeficiencies characterized by a broad spectrum of signaling defects,
including those dependent on Src family kinase-linked cell surface
receptors. A gain-of-function mutant, Btk*, induces the growth of
fibroblasts in soft agar and relieves the interleukin-5 dependence of a
pre-B-cell line. To genetically define Btk signaling pathways, we used a
strategy to either activate or inactivate Src family kinases in fibroblasts
that express Btk*. The transformation potential of Btk* was dramatically
increased by coexpression with a partly activated c-Src mutant (E-378
--> G). This synergy was further potentiated by deletion of the Btk Src
homology 3 domain. Downregulation of Src family kinases by the C-terminal
Src kinase (Csk) suppressed Btk* activation and biological potency. In
contrast, kinase-inactive Csk (K-222 --> R), which functioned as a
dominant negative molecule, synergized with Btk* in biological
transformation. Activation of Btk* correlated with increased
phosphotyrosine on transphosphorylation and autophosphorylation sites.
These findings suggest that the Src and Btk kinase families form specific
signaling units in tissues in which both are expressed.
Copyright © 1996, American Society for Microbiology
Regulation of Btk by Src family tyrosine kinases
Department of Microbiology, Howard Hughes Medical Institute, University of California--Los Angeles, 90095-1662, USA.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»